Related Experiment Video
Updated: Jun 29, 2026
Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
Published on: March 19, 2013
Mini Review: Recent Advances in the Cell-Based Therapies for Cardiac Regeneration
Lan Luo1,2, Tao-Sheng Li2
1Medical Technology School of Xuzhou Medical University, Xuzhou, Jiangsu, 221004, P.R. China
Insights
Stem cell therapy offers a promising new approach for treating heart failure, a leading cause of death. Research explores various cell types and direct reprogramming for cardiac repair and cardiovascular disease (CVD) treatment.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Cardiovascular diseases (CVDs) are a major global health burden, with current treatments only delaying disease progression.
- Stem cell therapy is emerging as a potent strategy for heart failure treatment and prevention.
- Identifying optimal cell types for cardiac repair is crucial.
Purpose of the Study:
- To summarize recent advancements in cell-based cardiac regeneration therapies.
- To explore diverse cell types investigated for repairing heart injuries.
- To discuss challenges and future directions for cell therapies in treating cardiovascular diseases.
Main Methods:
- Review of current literature on stem cell applications in cardiovascular disease.
- Analysis of various cell types, including skeletal myoblasts, embryonic stem cells, induced pluripotent stem cells, bone marrow-derived stem cells, mesenchymal stem cells, and resident cardiac stem cells.
- Examination of direct cardiac fibroblast reprogramming into cardiomyocytes.
Main Results:
- Multiple cell types show potential for cardiac regeneration.
- Direct reprogramming offers a novel pathway for generating new cardiomyocytes.
- Significant progress has been made in exploring cell-based strategies for CVDs.
Conclusions:
- Stem cell therapy holds significant promise for treating heart failure and cardiovascular diseases.
- Further research is needed to overcome challenges and optimize cell-based therapeutic approaches.
- Diverse cell sources and reprogramming techniques are advancing cardiac regeneration.
Abstract:
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally, and traditional pharmaceutical and surgical interventions delay the progression of CVDs. Recently, stem cell therapy has emerged as a promising candidate for treating and preventing heart failure. Increasing efforts have been devoted towards the exploration and identification of potential cell types to repair the injured heart, such as skeletal myoblasts, embryonic, induced pluripotent, bone marrowderived, mesenchymal, and resident cardiac stem cells. In addition, direct reprogramming of cardiac fibroblasts into cardiomyocytes represents a novel approach to cardiac regeneration. Herein, we summarize the recent progress in the use of various cell types for cardiac regeneration and discuss major challenges and future perspectives of cell-based therapies for CVDs.
